剰余金の配当（中間配当）、有価証券及び投資有価証券の取得による支出、売上収益（IFRS）他2件
- 【期間】
| 年度 | 剰余金の配当（中間配当） | 有価証券及び投資有価証券の取得による支出 | 売上収益（IFRS） | 全事業営業利益又は全事業営業損失（△） - 医薬・バイオケミカル | 純資産の部合計 |
|---|
| 2008/12 | - | | -21.4億 | | - | | - | | 1.15兆 | |
| 2009/12 | - | | -1373億 | 赤拡 | - | | - | | 1.2兆 | +4.2% |
| 2010/03 | - | | -3.08億 | 赤縮 | - | | - | | - | |
| 2010/06 | - | | -3.83億 | 赤拡 | - | | - | | - | |
| 2010/09 | - | | -865億 | 赤拡 | - | | - | | - | |
| 2010/12 | - | | -870億 | 赤拡 | - | | - | | 1.16兆 | -3.3% |
| 2011/03 | - | | -81.9億 | 赤縮 | - | | - | | 1.17兆 | +0.7% |
| 2011/06 | - | | -43.4億 | 赤縮 | - | | - | | 1.2兆 | +3.2% |
| 2011/09 | - | | -2464億 | 赤拡 | - | | - | | 1.16兆 | -3.7% |
| 2011/12 | -130億 | | -443億 | 赤縮 | - | | - | | 1.05兆 | -9.6% |
| 2012/03 | - | | - | | - | | - | | 1.1兆 | +5% |
| 2012/06 | - | | -46.1億 | 赤縮 | - | | - | | 1.12兆 | +1.9% |
| 2012/09 | - | | - | | - | | - | | 1.07兆 | -4.8% |
| 2012/12 | -130億 | 赤縮 | -96.4億 | 赤拡 | - | | 555億 | | 1.15兆 | +8.2% |
| 2013/03 | - | | - | | - | | - | | 1.28兆 | +10.8% |
| 2013/06 | - | | -24.6億 | 赤縮 | - | | - | | 1.33兆 | +3.8% |
| 2013/09 | - | | - | | - | | - | | 1.27兆 | -4.3% |
| 2013/12 | - | | -44.2億 | 赤拡 | - | | 543億 | -2.1% | 1.3兆 | +2.5% |
| 2014/03 | - | | - | | - | | - | | 1.31兆 | +0.6% |
| 2014/06 | - | | -81.5億 | 赤拡 | - | | - | | 1.31兆 | +0% |
| 2014/09 | - | | - | | - | | - | | 1.31兆 | -0.1% |
| 2014/12 | - | | -267億 | 赤拡 | - | | 389億 | -28.5% | 1.34兆 | +2.1% |
| 2015/03 | - | | - | | - | | - | | 1.06兆 | -20.5% |
| 2015/06 | - | | -57.4億 | 赤縮 | - | | - | | 1.08兆 | +1.9% |
| 2015/09 | - | | - | | - | | - | | 1.03兆 | -4.9% |
| 2015/12 | - | | -107億 | 赤拡 | - | | 468億 | +20.4% | 0.94兆 | -8.8% |
| 2016/03 | - | | - | | - | | - | | 0.92兆 | -2.2% |
| 2016/06 | - | | -55.4億 | 赤縮 | - | | - | | 0.89兆 | -2.8% |
| 2016/09 | - | | - | | - | | - | | 0.86兆 | -3.6% |
| 2016/12 | - | | -208億 | 赤拡 | - | | 347億 | -25.8% | 0.95兆 | +10% |
| 2017/03 | - | | - | | - | | - | | 0.99兆 | +4.2% |
| 2017/06 | - | | -109億 | 赤縮 | - | | - | | 1.13兆 | +14.7% |
| 2017/09 | - | | - | | - | | - | | 1.16兆 | +2.9% |
| 2017/12 | - | | - | | - | | - | | 0.95兆 | -18.4% |
| 2018/12 | - | | - | | 1.93兆 | | - | | 0.98兆 | +3.3% |
| 2019/03 | - | | - | | 0.43兆 | -77.5% | - | | - | |
| 2019/06 | - | | - | | 0.93兆 | +114.1% | - | | - | |
| 2019/09 | - | | - | | 1.44兆 | +54.6% | - | | - | |
| 2019/12 | - | | - | | 1.94兆 | +35% | - | | 1.04兆 | +6.1% |
| 2020/03 | - | | - | | 0.42兆 | -78.1% | - | | - | |
| 2020/06 | - | | - | | 0.87兆 | +105.5% | - | | - | |
| 2020/09 | - | | - | | 1.36兆 | +55.8% | - | | - | |
| 2020/12 | - | | - | | 1.85兆 | +36% | - | | 0.99兆 | -5.2% |
| 2021/03 | - | | - | | 0.41兆 | -77.9% | - | | - | |
| 2021/06 | - | | - | | 0.86兆 | +111.1% | - | | - | |
| 2021/09 | - | | - | | 1.33兆 | +53.5% | - | | - | |
| 2021/12 | - | | - | | 1.82兆 | +37.3% | - | | 1.01兆 | +2% |
| 2022/03 | - | | - | | 0.42兆 | -77.1% | - | | - | |
| 2022/06 | - | | - | | 0.92兆 | +120.1% | - | | - | |
| 2022/09 | - | | - | | 1.46兆 | +58.9% | - | | - | |
| 2022/12 | - | | - | | 1.99兆 | +36.5% | - | | 0.95兆 | -5.6% |
| 2023/03 | - | | - | | 0.45兆 | -77.4% | - | | - | |
| 2023/06 | - | | - | | 0.97兆 | +115.4% | - | | - | |
| 2023/09 | - | | - | | 1.55兆 | +59.5% | - | | - | |
| 2023/12 | - | | - | | 2.13兆 | +37.9% | - | | 0.96兆 | +1.4% |
| 2024/03 | - | | - | | 0.5兆 | -76.5% | - | | - | |
